Morgan Stanley Assumes Zenas Biopharma (ZBIO) at Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: ZBIO) | Delayed: 27.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.62 | 52 Week High | $50.95 | |||
| Open | $27.62 | 52 Week Low | $18.06 | |||
| Day High | $27.62 | P/E | N/A | |||
| Day Low | $27.62 | EPS | $0.00 | |||
| Volume | 105,568 | |||||
